Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role?
作者： Andy Whelan , Mark I Johnson
关键词:
摘要: Recently, there has been interest in lysergic acid diethylamide (LSD) and psilocybin for depression, anxiety fear of death terminal illness. The aim this review is to discuss the potential use LSD patients with persistent pain. are 5-hydroxytryptamine receptor agonists may interact nociceptive antinociceptive processing. Tentative evidence from a systematic suggests that (7 studies, 323 participants) (3 92 be beneficial depression associated distress life-threatening diseases. generally safe if administered by healthcare professional, although further investigations needed assess their utility pain, especially
leedsbeckett.ac.uk
futuremedicine.com 
sci-hub.se 参考文章(91)
S. Grof, L.E. Goodman, W.A. Richards, A.A. Kurland, LSD-assisted psychotherapy in patients with terminal cancer. International pharmacopsychiatry. ,vol. 8, pp. 129- 144 ,(1973) , 10.1159/000467984
Atsushi Tokunaga, Misako Saika, Emiko Senba, 5-HT2A receptor subtype is involved in the thermal hyperalgesic mechanism of serotonin in the periphery Pain. ,vol. 76, pp. 349- 355 ,(1998) , 10.1016/S0304-3959(98)00066-9
Teri S Krebs, Pål-Ørjan Johansen, Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials Journal of Psychopharmacology. ,vol. 26, pp. 994- 1002 ,(2012) , 10.1177/0269881112439253
Javeria A. Hashmi, Marwan N. Baliki, Lejian Huang, Alex T. Baria, Souraya Torbey, Kristina M. Hermann, Thomas J. Schnitzer, A. Vania Apkarian, Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits Brain. ,vol. 136, pp. 2751- 2768 ,(2013) , 10.1093/BRAIN/AWT211
Davide Anchisi, Marco Zanon, A Bayesian Perspective on Sensory and Cognitive Integration in Pain Perception and Placebo Analgesia PLOS ONE. ,vol. 10, pp. e0117270- ,(2015) , 10.1371/JOURNAL.PONE.0117270
Varsha Dutta, Repression of death consciousness and the psychedelic trip Journal of Cancer Research and Therapeutics. ,vol. 8, pp. 336- 342 ,(2012) , 10.4103/0973-1482.103509
Michael P. Bogenschutz, Matthew W. Johnson, Classic hallucinogens in the treatment of addictions. Progress in Neuro-psychopharmacology & Biological Psychiatry. ,vol. 64, pp. 250- 258 ,(2016) , 10.1016/J.PNPBP.2015.03.002
M. N. Baliki, A. T. Baria, A. V. Apkarian, The cortical rhythms of chronic back pain. The Journal of Neuroscience. ,vol. 31, pp. 13981- 13990 ,(2011) , 10.1523/JNEUROSCI.1984-11.2011
Patrick B. Wood, Mesolimbic dopaminergic mechanisms and pain control. Pain. ,vol. 120, pp. 230- 234 ,(2006) , 10.1016/J.PAIN.2005.12.014
Teri S. Krebs, Pål-Ørjan Johansen, Psychedelics and Mental Health: A Population Study PLoS ONE. ,vol. 8, pp. e63972- ,(2013) , 10.1371/JOURNAL.PONE.0063972